AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 171 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $5,784,000 | -61.4% | 75,000 | -57.9% | 0.21% | -65.9% |
Q2 2018 | $14,993,000 | +3.0% | 178,000 | 0.0% | 0.62% | -8.8% |
Q1 2018 | $14,557,000 | +19.0% | 178,000 | -16.8% | 0.68% | +6.9% |
Q4 2017 | $12,234,000 | -14.4% | 214,000 | 0.0% | 0.64% | -21.2% |
Q3 2017 | $14,285,000 | -7.7% | 214,000 | -28.9% | 0.81% | -16.0% |
Q2 2017 | $15,476,000 | -11.9% | 300,800 | 0.0% | 0.96% | -17.1% |
Q1 2017 | $17,567,000 | +40.0% | 300,800 | 0.0% | 1.16% | +42.4% |
Q4 2016 | $12,552,000 | -21.0% | 300,800 | 0.0% | 0.82% | -15.8% |
Q3 2016 | $15,888,000 | +26.1% | 300,800 | 0.0% | 0.97% | +25.8% |
Q2 2016 | $12,602,000 | +3.2% | 300,800 | 0.0% | 0.77% | +13.0% |
Q1 2016 | $12,212,000 | -37.5% | 300,800 | 0.0% | 0.68% | -30.1% |
Q4 2015 | $19,528,000 | +13.0% | 300,800 | +22.8% | 0.98% | -2.8% |
Q3 2015 | $17,287,000 | -6.4% | 244,900 | +47.4% | 1.00% | +0.5% |
Q2 2015 | $18,471,000 | +17.9% | 166,200 | 0.0% | 1.00% | -15.3% |
Q1 2015 | $15,673,000 | -45.8% | 166,200 | -35.6% | 1.18% | -62.7% |
Q4 2014 | $28,929,000 | +9.3% | 258,200 | -40.2% | 3.16% | -14.6% |
Q3 2014 | $26,479,000 | +17.8% | 431,600 | -12.0% | 3.70% | +21.0% |
Q2 2014 | $22,475,000 | +26.4% | 490,500 | +8.0% | 3.06% | +10.7% |
Q1 2014 | $17,782,000 | +255.6% | 454,200 | +117.5% | 2.76% | +79.1% |
Q4 2013 | $5,001,000 | – | 208,800 | – | 1.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,710,061 | $67,074,010 | 1.80% |
Bellevue Group AG | 4,013,500 | $99,334,125 | 1.60% |
Eagle Health Investments LP | 267,630 | $6,623,843 | 1.46% |
ARMISTICE CAPITAL, LLC | 3,324,000 | $82,269,000 | 1.26% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $11,236,500 | 0.61% |
Frazier Life Sciences Management, L.P. | 292,002 | $7,227,050 | 0.48% |
ArrowMark Colorado Holdings LLC | 1,573,359 | $38,940,635 | 0.47% |
Deep Track Capital, LP | 422,247 | $10,450,613 | 0.40% |
FARALLON CAPITAL MANAGEMENT LLC | 2,750,829 | $68,083,018 | 0.34% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 24,000 | $593,520 | 0.20% |